Greystar Hires Matt DeNoble as Senior Director of Life Science Investment

Greystar Real Estate Partners has appointed Matt DeNoble as Senior Director of Life Science Investment Management. In this role, he will be responsible for expanding Greystar’s national life sciences strategy with a focus on the Boston market and other top-tier life science clusters.
DeNoble brings extensive experience in asset management, having overseen leases, dispositions and recapitalizations over the past two decades. He has executed more than 100 leases/renewals totaling 2 million square feet; disposed of 3 million square feet; and completed $1.3 billion in recapitalizations during his career so far. As Senior Director of Life Science Investment Management at Greystar, DeNoble will lead development of an asset management platform to strengthen tenant relationships while also supporting new acquisitions and lease-ups.
“I’m excited to continue elevating Greystar as a national leader in the life sciences space,” said DeNoble “and identify large-scale core opportunities in areas propelled by the innovation economy.”